Vervaardiging van farmaceutische grondstoffen en producten

NACE 21

Active companies, 5-year failure rate, regional split and recent bankruptcies for this NACE sector.

6,826 active companies with this primary NACE

Active companies6,826

Bankruptcies (5y)17

Failure rate0.25%

Regions covered4

Provinces covered11

Bankruptcies and the failure rate are attributed by each company's current primary NACE, not the NACE at the time of bankruptcy (which the gazette does not record).

Sector key figures

fiscal year 2024 · median over 46 filed annual accounts (NACE division 21)

Median solvency

46.9%

Median equity

€108k

Median net result

€-1k

Annual accounts in sample

Source: NBB annual accounts, all schema types combined. Medians computed internally.

Regional split

by region

Vlaanderen 313 · 56.5%

Wallonië 175 · 31.6%

Brussel 56 · 10.1%

Unknown 10 · 1.8%

Recent bankruptcies in this sector

Date	Company
24-04-2026	San'Up BE 0693.818.729
10-03-2026	Amalus Therapeutics BE 0803.929.268
27-10-2025	DESCAR BE 0405.332.613
27-10-2025	ALLBOX BE 0417.348.339
27-10-2025	UNIZIMA BE 0744.643.759
27-10-2025	Quantoom Biosciences BE 0744.643.858
10-10-2025	UNIVERCELLS BE 0502.742.288
02-09-2025	EXOTHERA BE 0744.643.660

Geographic distribution

by province · based on the establishment address

West Flanders WVL 38

East Flanders OVL 86

Antwerp ANT 99

Flemish Brabant VLB 56

Limburg LIM 34

Brussels BRU 56

Hainaut HAI 51

Walloon Brabant WBR 46

Namur NAM 11

Liège LIE 53

Luxembourg LUX 14

fewer moremax 99